Metraipolis › archive › dc_5a21c021a522

Antibacterial properties of polydopamine-modified ZnO nanoparticles composite films for oral therapeutic applications — Europe PMC PMID:41493729

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41493729
DOI: 10.1186/s11671-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-11-07T01:01:25.972Z
SHA-256 of the archived text: 36797122ea0b1f224b37d198a13bbc33e3183017fe8c41b014bf3325ff46c1a4
Stable URL of this page: https://metraipolis.com/documento/dc_5a21c021a522

How to cite

Antibacterial properties of polydopamine-modified ZnO nanoparticles composite films for oral therapeutic applications — Europe PMC PMID:41493729 — Europe PMC (en), https://europepmc.org/article/MED/41493729 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a21c021a522 (Metraipolis archive dc_5a21c021a522, sha256 36797122ea0b1f224b37d198a13bbc33e3183017fe8c41b014bf3325ff46c1a4)

BibTeX

@misc{dc5a21c021a522,
  title = {Antibacterial properties of polydopamine-modified ZnO nanoparticles composite films for oral therapeutic applications — Europe PMC PMID:41493729},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41493729},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a21c021a522; sha256 36797122ea0b1f224b37d198a13bbc33e3183017fe8c41b014bf3325ff46c1a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41493729. Agents can read the archived copy with the MCP tool read_document.